Latest Articles
Endometriosis poses substantial burden on Australia’s health system - The Hippocratic Post
Endometriosis poses substantial burden on Australia’s health system The Hippocratic Post
Published: Jan. 21, 2025, 12:05 p.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - EIN News
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR EIN News
Published: Jan. 21, 2025, 10:38 a.m.
Causal analysis of dietary preferences and the risk of endometriosis using large-scale population data - Nature.com
Causal analysis of dietary preferences and the risk of endometriosis using large-scale population data Nature.com
Published: Jan. 21, 2025, 6:16 a.m.
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning - Frontiers
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning Frontiers
Published: Jan. 21, 2025, 4:35 a.m.
Estate agent who was diagnosed with endometriosis wins £31k - MSN
Estate agent who was diagnosed with endometriosis wins £31k MSN
Published: Jan. 21, 2025, 3:51 a.m.
Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis - BMC Public Health
Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis BMC Public Health
Published: Jan. 21, 2025, 1:41 a.m.
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - ABN Newswire
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR ABN Newswire
Published: Jan. 21, 2025, 12:38 a.m.
Endometriosis: A Chronic Disease - MSN
Endometriosis: A Chronic Disease MSN
Published: Jan. 20, 2025, 3:22 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
Published: Jan. 20, 2025, 8:21 a.m.
Link copied to clipboard!